Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826563 · ClinicalTrials.gov registry record · NA
Melatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk Symptoms
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03826563 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 21 participants.
The verdict
NCT03826563, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Randomized control trial assessing supplemental melatonin for youth with at-risk or psychotic symptoms.
Interventions
- OTHER Placebo
- DRUG oral melatonin tablets (NatureMade brand)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-01-18 |
| Est. Completion | 2023-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03826563
The ClinicalTrials.gov registry entry for NCT03826563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03826563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03826563 about?
NCT03826563 is a clinical study titled "Melatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk Symptoms". Randomized control trial assessing supplemental melatonin for youth with at-risk or psychotic symptoms.
What is the current status of trial NCT03826563?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-01-18. Estimated completion is 2023-04-07.
What interventions are being tested in trial NCT03826563?
The interventions under investigation include: Placebo (OTHER), oral melatonin tablets (NatureMade brand) (DRUG).
Who is sponsoring clinical trial NCT03826563?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.